Answers are grounded in this paper and cite their sources.
Salivary exosomal miR-24-3p is a potential novel diagnostic biomarker for OSCC, and miR-24-3p can maintain the proliferation of OSCC cells through targeting PER1.
No takes yet. Share an insight, caveat, or question.
He et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: